ENTA vs. ASST

Last updated Jun 13, 2026

ENTA (Enanta Pharmaceuticals, Inc.) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. ENTA operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past 3 years, ENTA returned -21.72%/yr vs -56.18%/yr for ASST. At a 0.07 correlation, their price movements are largely independent.

Performance

ENTA vs. ASST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enanta Pharmaceuticals, Inc. (ENTA) and Asset Entities Inc. Class B Common Stock (ASST). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ENTA achieves a -24.54% return, which is significantly lower than ASST's 2.64% return.

ENTA

• 1D: 3.39%
• 1M: -13.83%
• YTD: -24.54%
• 6M: -19.21%
• 1Y: 58.67%
• 3Y*: -21.72%
• 5Y*: -24.07%
• 10Y*: -6.52%

ASST

• 1D: 3.91%
• 1M: -9.77%
• YTD: 2.64%
• 6M: -12.25%
• 1Y: -86.92%
• 3Y*: -56.18%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ENTA vs. ASST - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ENTA Enanta Pharmaceuticals, Inc.	-24.54%	174.26%	-38.89%	-82.16%
ASST Asset Entities Inc. Class B Common Stock	2.64%	50.46%	-84.65%	-89.13%

Correlation

The correlation between ENTA and ASST is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (All Time) Calculated using the full available price history since Feb 3, 2023	0.07

Fundamentals

Market Cap ENTA : $343.81M ASST : $933.69M
EPS ENTA : -$2.67 ASST : -$25.54
PS Ratio ENTA : 4.00 ASST : 71.38
Total Revenue (TTM) ENTA : $69.21M ASST : $5.73M
Gross Profit (TTM) ENTA : $33.44M ASST : -$7.43M
EBITDA (TTM) ENTA : -$61.85M ASST : -$304.63M

Return for Risk

ENTA vs. ASST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENTA

ENTA Risk / Return Rank: 72
ENTA Sharpe Ratio Rank: 61
ENTA Sortino Ratio Rank: 78
ENTA Omega Ratio Rank: 77
ENTA Calmar Ratio Rank: 73
ENTA Martin Ratio Rank: 70

ASST

ASST Risk / Return Rank: 15
ASST Sharpe Ratio Rank: 19
ASST Sortino Ratio Rank: 14
ASST Omega Ratio Rank: 17
ASST Calmar Ratio Rank: 6
ASST Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENTA vs. ASST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ENTA	ASST	Difference
Sharpe ratio: Return per unit of total volatility	0.56	-0.54	+1.10
Sortino ratio: Return per unit of downside risk	2.07	-0.86	+2.93
Omega ratio: Gain probability vs. loss probability	1.27	0.91	+0.36
Calmar ratio: Return relative to maximum drawdown	1.78	-0.92	+2.69
Martin ratio: Return relative to average drawdown	3.36	-1.12	+4.48

ENTA vs. ASST - Sharpe Ratio Comparison

The current ENTA Sharpe Ratio is 0.56, which is higher than the ASST Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of ENTA and ASST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ENTA vs. ASST - Drawdown Comparison

The maximum ENTA drawdown since its inception was -96.63%, roughly equal to the maximum ASST drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for ENTA and ASST.

Drawdown Indicators

	ENTA	ASST	Difference
Max Drawdown Largest peak-to-trough decline	-96.63%	-98.78%	+2.15%
Max Drawdown (1Y) Largest decline over 1 year	-34.30%	-95.98%	+61.68%
Max Drawdown (3Y) Largest decline over 3 years	-82.38%	-97.25%	+14.87%
Max Drawdown (5Y) Largest decline over 5 years	-95.62%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-96.63%	—	—
Current Drawdown Current decline from peak	-90.58%	-97.42%	+6.84%
Average Drawdown Average peak-to-trough decline	-49.27%	-90.39%	+41.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.11%	78.47%	-60.36%

Volatility

ENTA vs. ASST - Volatility Comparison

The current volatility for Enanta Pharmaceuticals, Inc. (ENTA) is 13.67%, while Asset Entities Inc. Class B Common Stock (ASST) has a volatility of 23.80%. This indicates that ENTA experiences smaller price fluctuations and is considered to be less risky than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ENTA	ASST	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.67%	23.80%	-10.13%
Volatility (6M) Calculated over the trailing 6-month period	35.48%	81.69%	-46.21%
Volatility (1Y) Calculated over the trailing 1-year period	109.73%	162.68%	-52.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	73.36%	322.54%	-249.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.69%	322.54%	-261.85%

Dividends

ENTA vs. ASST - Dividend Comparison

Neither ENTA nor ASST has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ENTA and ASST in my portfolio?

ENTA and ASST have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ENTA or ASST?

ASST has higher volatility (23.80%) compared to ENTA (13.67%). In terms of maximum drawdown, ENTA dropped -96.63% vs ASST's -98.78%.

Which has better risk-adjusted returns?

ENTA currently has the higher Sharpe Ratio (0.56 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.